Ruxolitinib 10mg tablets
NHS hospitals in England used £26,666,003 of indicative cost of Ruxolitinib 10mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 23.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ruxolitinib 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ruxolitinib 10mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £1,730,124 |
| Western Sussex Hospitals Nhs Found Trust | £929,118 |
| University Hpls Of Leicester Nhs Trust | £842,520 |
| Derby Teaching Hospitals Nhs Found Trust | £808,554 |
| The Christie Nhs Foundation Trust | £721,650 |
| Manchester University Nhs Ft | £668,916 |
| Sheffield Teaching Hospitals Nhs Trust | £639,744 |
| Hull And East Yorkshire Hpls Nhs Trust | £625,158 |
| University College London Foundation Tr | £592,967 |
| Univ Hpl B/Ham Nhs Foundation Trust | £586,194 |
The primary-care picture
Ruxolitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ruxolitinib medicine page.